NCL1, A Highly Selective Lysine-Specific Demethylase 1 Inhibitor, Suppresses Castration-Resistant Prostate Cancer Growth via Regulation of Apoptosis and Autophagy

Lignende værker

• NCL1, a highly selective lysine-specific demethylase 1 inhibitor, suppresses prostate cancer without adverse effect
  af: Etani, Toshiki, et al.
  Udgivet: (2014)
• Selective lysine‐specific demethylase 1 inhibitor, NCL1, could cause testicular toxicity via the regulation of apoptosis
  af: Nozaki, Satoshi, et al.
  Udgivet: (2020)
• Luteolin suppresses bladder cancer growth via regulation of mechanistic target of rapamycin pathway
  af: Iida, Keitaro, et al.
  Udgivet: (2020)
• Recruitment of miR-8080 by luteolin inhibits androgen receptor splice variant 7 expression in castration-resistant prostate cancer
  af: Naiki-Ito, Aya, et al.
  Udgivet: (2020)
• GPX2 promotes development of bladder cancer with squamous cell differentiation through the control of apoptosis
  af: Naiki, Taku, et al.
  Udgivet: (2018)